Why One Fund Sold All Its Stock in a Healthcare REIT Up 77% Over the Past Year

Global IMC disclosed in an SEC filing that it sold its entire 222,038-share position in American Healthcare REIT (AHR) during Q3, a transaction valued at roughly $8.16 million and representing 2.1% of the fund's prior AUM. AHR, trading at $48.13 and up ~77% over the past year, is a ~$9 billion market-cap healthcare REIT with TTM revenue of $2.20 billion and net income of $27.26 million; the company reported Q3 GAAP net income of $55.9 million ($0.33), normalized FFO of $0.44, same-store NOI growth of 16.4% YoY, and raised 2025 normalized FFO guidance to as much as $1.72 and same-store NOI growth up to 15%, indicating the sale appears to be liquidity-taking after a strong rally rather than a reflection of weakening fundamentals.

Analysis

Market structure: Global IMC’s $8.16M full exit in AHR (222k shares) is immaterial versus AHR’s $9B market cap but signals tactical profit-taking after a 77% YTD rally. Winners are operators and peers in senior housing/integrated health campuses that benefit from rising same-store NOI (AHR reported +16.4% YoY); losers are momentum holders who use small positions for liquidity and may create transient supply into strength. Cross-asset: expect muted credit-spread compression in healthcare REITs if fundamentals hold, limited FX/commodity impact, and potential short-term dip in implied vol for AHR options as selling dries up.

Risk assessment: Tail risks include a 100–200bp adverse move in rates (would re-rate P/FFO multiples down >10%), adverse CMS/Medicaid reimbursement actions, or occupancy shocks >300bps; operational dependency on third‑party operators raises execution risk. Timeframe: days—technical/seasonal liquidations; weeks–months—earnings cadence (watch next 90 days for occupancy/FFO beats); quarters–years—demographics support secular demand but valuation cyclicality remains. Catalysts: quarterly FFO beats, M&A, or macro rate moves could sharply reprice shares.

Trade implications: Direct: consider establishing a 1–3% notional long in AHR (NYSE:AHR) on pullback to $42–45 (~10–13% downside from $48.13) where P/FFO moves closer to 25x; target 12‑month upside to $60 if FFO guide of $1.72 holds and same-store NOI sustains. Pair: go long AHR vs short VNQ-sized notional to express healthcare REIT idiosyncratic upside while hedging REIT beta. Options: buy 3–6 month 10% OTM call spreads (cost-limited upside) ahead of next quarterly results, or buy 3‑month puts if 10yr Treasury >4.5% to hedge rate shock.

Contrarian angles: Consensus misreads the sale as a signal of business weakness; it's more likely capital recycling from concentrated portfolios—$8M is a liquidity clipping, not a vote of no confidence. Reaction is underdone on fundamentals (AHR FFO guide to $1.72) but possibly overdone on valuation: fair value at 20–25x FFO implies $34–43; watch occupancy and FFO momentum over next two quarters. Unintended consequence: crowded healthcare REIT longs could amplify downside on a macro rate pause; set hard stops (≈18% from entry) and reassess if same-store NOI decelerates below +5% YoY.

Key Decisions for Investors

• Establish a 1–3% long position in AHR on a retracement to $42–45 (≈10–13% pullback from $48.13). Rationale: entry moves P/FFO toward 25x; target $60 in 12 months if FFO approaches $1.72 and same-store NOI stays >10%; set a stop-loss at ~18%.
• Implement a pair trade: long AHR equal‑notional vs short VNQ (or sector REIT ETF) to isolate healthcare REIT outperformance while hedging REIT beta; rebalance after quarterly earnings within 30 days.
• Buy a 3–6 month AHR 10% OTM call spread sized at 0.5–1% notional as a directional, limited‑risk upside play into the next earnings; alternatively buy 3‑month puts if 10yr Treasury >4.5% to protect against a rate shock.
• Reduce exposure by 1–2% to long-duration non-health REITs (office/retail) and redeploy into healthcare REITs if AHR same-store NOI remains >10% and occupancy holds; re-evaluate after next two quarterly reports.
• Monitor specific catalysts over next 30–60 days: AHR quarterly FFO vs guidance, same-store NOI, occupancy trends, and any CMS/Medicaid policy notices; only increase size if FFO beats by ≥5% and occupancy remains stable.